StreetAlpha
Sagimet Biosciences Inc. · SEC Form 4

SGMT Insider Trading

From SEC Form 413 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Sagimet Biosciences Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $4.9M sold.

← SGMT stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$4.9M10 sales · 5 insiders
Net−$4.9Mbought minus sold
Planned sales86%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJan2026-02: sold $105KFebMarAprMayJun2026-07: sold $719KJul2026-08: sold $3.8MAugSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when SGMT insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an SGMT officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every SGMT insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Aug 14, 2026George KembleDirectorSale plan350,987$10.23$3.6M62,161Aug 17Form 4
Aug 11, 2026George KembleDirectorSale plan20,206$9.95$201K62,161Aug 12Form 4
Jul 20, 2026George KembleDirectorSale plan18,844$7.46$141K62,161Jul 22Form 4
Jul 20, 2026Elizabeth RozekChief Legal & Admin. OfficerSale10,545$7.76$82K224,414Jul 22Form 4
Jul 20, 2026David HappelPresident & CEOSale64,051$7.76$497K741,570Jul 22Form 4
Feb 10, 2026Elizabeth RozekChief Legal & Admin. OfficerSale2,622$5.36$14K190,959Feb 12Form 4
Feb 10, 2026Eduardo Bruno MartinsChief Medical OfficerSale3,640$5.36$20K103,296Feb 12Form 4
Feb 10, 2026Thierry ChaucheCFOSale1,312$5.36$7K15,688Feb 12Form 4
Feb 10, 2026David HappelPresident & CEOSale12,101$5.36$65K677,621Feb 12Form 4
Nov 20, 2025George KembleExecutive ChairmanSale plan37,688$7.69$290K81,005Nov 21Form 4
Jul 21, 2025Elizabeth RozekGeneral Counsel and CCOSale10,780$9.13$98K183,726Jul 23Form 4
Jul 21, 2025Eduardo Bruno MartinsChief Medical OfficerSale8,277$9.13$76K106,936Jul 23Form 4
Jul 21, 2025David HappelPresident & CEOSale65,478$9.13$598K689,722Jul 23Form 4

SGMT insider trading FAQ

Are SGMT insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of SGMT on the open market in 0 trades, and 5 sold $4.9M in 10 trades, 86% of that under pre-arranged trading plans.

When did an SGMT insider last buy shares?

There has been no open market insider purchase of SGMT in the last two years.

When did an SGMT insider last sell shares?

George Kemble (Director) sold 350,987 shares for $3.6M on Aug 14, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice